nylidrin has been researched along with Retinitis Pigmentosa in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Retinitis Pigmentosa: Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KOMI, T | 1 |
| UCHIDA, S | 1 |
1 other study available for nylidrin and Retinitis Pigmentosa
| Article | Year |
|---|---|
[Effectiveness of Verina (Nylidrin) in retinitis pigmentosa].
Topics: Humans; Nylidrin; Retinitis Pigmentosa; Vasodilator Agents | 1962 |